MNPR
Monopar Therapeutics Inc
89.40$
-7.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.7% | 99.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.8% | 99.9% | 99.8% | 99.8% | 99.8% | |
| 64.2% | 98.9% | 87.6% | 85.2% | 99.2% | 76.0% | 72.1% | 73.3% | 88.5% | 43.9% | 38.1% | 39.1% | |
| 98.9% | 98.9% | 98.7% | 99.2% | 99.2% | 99.9% | 99.0% | 98.9% | 99.6% | 99.8% | 99.6% | 99.5% | |
| 23.1% | 23.9% | 16.1% | 15.2% | 18.5% | 8.7% | 2.7% | 3.1% | 1.8% | 2.1% | 1.9% | 3.1% | |
| 23.1% | 23.9% | 16.1% | 15.2% | 18.5% | 8.7% | 2.7% | 2.9% | 1.8% | 1.9% | 1.8% | 3.0% | |
| – | – | – | – | – | – | – | – | 0.0% | – | – | – | |
| 23.1% | 23.9% | 16.1% | 15.2% | 18.5% | 3.7% | 2.7% | 2.9% | 1.8% | 1.9% | 1.8% | 3.0% | |
| 76.9% | 76.1% | 83.9% | 84.8% | 81.5% | 91.3% | 97.3% | 96.9% | 98.2% | 97.9% | 98.1% | 96.9% | |
| -679.5% | -819.7% | -694.0% | -885.3% | -1,068.7% | -125.7% | -142.4% | -150.1% | -58.5% | -63.6% | -67.7% | -73.1% | |
| 164.3% | 202.9% | 179.3% | 243.9% | 189.2% | 19.0% | 12.7% | 13.0% | 4.9% | 4.8% | 6.2% | 6.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.